Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Sulfur burps can be a common mild side effect of Zepbound due to slower stomach emptying, shifts in gut bacteria, or higher protein intake and are usually harmless if occasional and not accompanied by severe pain, bleeding, or systemic symptoms. Red flags include persistent foul-smelling burps lasting over a week, severe upper abdominal pain or cramping, blood in vomit or stool, rapid weight loss, or signs like dizziness, rapid heartbeat, or difficulty breathing.
See the checklist below to determine if your symptoms fall into typical side effects or need prompt medical attention, and review the full details below for practical tips and next steps.
Starting Zepbound can be a game-changer for weight management, but some people report unusual side effects—like sulfur burps. If you're asking yourself, "Are my Zepbound sulfur burps after starting a red flag?" you're in the right place. Below is a clear, concise checklist to help you understand what's normal versus what needs attention.
Sulfur burps (characterized by a "rotten egg" smell) can stem from:
Use this checklist to gauge whether your sulfur burps are a typical side effect or something to watch more closely. Tick off any that apply:
If most boxes are checked, your sulfur burps likely fall into the "common, mild" category. If several boxes are unchecked, keep reading.
If your sulfur burps are mild but annoying, try these strategies:
Even if you've managed mild burps before, be alert for:
If any of these occur, it's time to pause self-management and seek professional guidance.
Still unsure whether your symptoms require a doctor's visit? Get instant clarity by using this Medically approved LLM Symptom Checker Chat Bot to evaluate your symptoms and understand whether you need immediate medical attention.
Your healthcare provider can determine if you should adjust your Zepbound dose, add supportive treatment, or investigate other causes.
Sulfur burps after starting Zepbound can be annoying but are often benign and manageable. However, persistent or severe symptoms may signal something more serious. Trust your instincts: if in doubt, do the online symptom check or reach out to your healthcare professional right away. Always speak to your doctor about anything that could be life threatening or serious.
(References)
* Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
* Davies MJ, Færch L, Jeppesen OK, et al. Efficacy and Safety of Tirzepatide in Type 2 Diabetes Mellitus and Obesity: A Systematic Review and Meta-Analysis. Diabetes Obes Metab. 2023 Jul;25(7):1987-2000. doi: 10.1111/dom.15082. Epub 2023 Apr 19. PMID: 37078335.
* Vella A. Effects of GLP-1 Agonists on Gastric Motility. Can J Diabetes. 2017 Aug;41(4):347-352. doi: 10.1016/j.jcjd.2017.02.016. PMID: 28802268.
* Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.
* Min T, Chon S. A Systematic Review and Meta-Analysis of Adverse Events of Tirzepatide, a Novel Dual GIP and GLP-1 Receptor Agonist. J Clin Med. 2023 Jul 26;12(15):4945. doi: 10.3390/jcm12154945. PMID: 37573033; PMCID: PMC10438151.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.